Form 4: Annovis Bio Director Acquires Shares

Michael B. Hoffman, a Director at Annovis Bio, Inc., acquired 713,800 shares of common stock on April 2, 2026.

Summary

• Michael B. Hoffman, a Director at Annovis Bio, Inc. (ANVS), acquired 713,800 shares of common stock on April 2, 2026, at a price of $2.10 per share.
• Following this transaction, Hoffman beneficially owns 3,288,539 shares of common stock.
• Of the total shares owned, 223,357 shares are held indirectly through The Hoffman Family Trust.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to the director's acquisition of shares, which can be interpreted as a sign of confidence, but it does not provide new financial information or strategic updates.

Positives

• Director acquisition of a significant number of shares can signal confidence in the company's future prospects.
• The acquisition of 713,800 shares at a stated price indicates a belief in the current valuation or undervaluation of the stock.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that director share acquisitions are common filings under Section 16(a) and can be interpreted as a positive signal by the market, though they do not inherently reflect the company's financial performance or future outlook.

Stakeholder Impact

• Shareholders may view this acquisition positively, interpreting it as a sign of insider confidence in the company's value.
• Employees may also see this as a positive signal regarding the company's stability and future.

Key Dates

Keywords

Annovis Bio, ANVS, Form 4, Insider Trading, Director, Common Stock, Share Acquisition